| Application no. and date | 19746252.6 (espacenet) (Federated) (European Patent Register), 20190711 | | Patent/reg. no. and date | DK/EP 3820874, 20221130 | | Publication date | 20210519 | | Priority no. and date | US 201862697100 P, 20180712, US 201962825172 P, 20190328 | | EP pub. no. and date |
EP 3820874 20210519 | | Effective date | | | Applicant/owner | Eli Lilly and Company, Lilly Corporate Center
Indianapolis, IN 46285, US | | Applicant ref. no. | V451733DK00 | | Inventor | SALL, Daniel Jon, c/o ELI LILLY AND COMPANY
P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
COHEN, Jeffrey Daniel, c/o ELI LILLY AND COMPANY P.O. Box 6288
Indianapolis, Indiana 46206-6288, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/436 (2006.01) , A61P 35/00 (2006.01) , C07D 491/052 (2006.01) | | Title | Selektive estrogenreceptornedbrydere | | Int. application no. | US2019041342 | | Int. publication no. | WO2020014440 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
